MC

Moelis & Company

MCFinancial ServicesNASDAQ

Capital Markets · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.52B
+27.0% YoY
Net Income
$233.0M
+71.3% YoY
EBITDA
$285.7M
+55.8% YoY

Scan Results

Daily timeframe
5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 MACD Negative CrossoverHistogram -0.2893, negative momentum
Jul 10CONFIRMED MACD Negative CrossoverHistogram -0.1012, negative momentum
Above MA200+0.4% from MA200, price crossed above
Above MA150+0.3% from MA150, price crossed above
About Moelis & Company

Moelis & Company operates as an investment banking advisory company in North and South America, Europe, the Middle East, Asia, and Australia. The $5.02B market capitalization puts MC squarely in mid-cap range for its industry. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic advisory, capital markets, capital structure advisory, and private capital advisory.

Key stats
Market Cap$5.02B
P/E (TTM)24.91
Fwd P/E17.26
EPS$2.71
Beta1.85
52W Change-4.2%
Dividend Yield3.75%
ROE41.8%
Analysis

The company holds $152.9M in cash, though total debt stands at $267.2M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Return on equity stands at 41.8%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 19.9% further supports the picture of efficient asset utilization. Revenue has been relatively flat, moving from $1.54B (2021) to $1.52B (2025).

Moelis & Company's elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Moelis & Company's trajectory.

Links
More Financial Services stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms